Health And Dental Helper

GlobalData

, the new report of the expert analysis of the industry “Osteoarthritis – Drug Pipeline Analysis and Forecasts to 2016″ is an essential source of information and analysis on the world market osteoarthritis. The report identifies key trends shaping the market and go global osteoarthritis. The report also provides an overview of the competitive environment prevalent and emerging players should bring significant changes in the positioning of market leaders in the existing market. In particular, the report provides valuable information about the products pipeline in the world of osteoarthritis.

This report was prepared using data and information from proprietary databases that contain primary and secondary research and internal analysis by the team global data from industry experts.

The report analyzes the market opportunities and challenges for the global market osteoarthritis. Its scope includes />
- Geographies in this report are br including the U.S., Britain, Italy, Spain, Germany, France and Japan </> -. Data analysis pipelines provide a split between the different phases through the mechanism of action developed and emerging trends. The major classes of mechanism are the serotonin-norepinephrine reuptake inhibitors, regulators of calcium homeostasis and inhibitors of proton pump inhibitors, 5-lipoxygenase and cyclooxygenase, opioid-receptor agonist that stem cell therapy, synthesizer cartilage cells
-. The analysis of competition in the current and future global market osteoarthritis. Key market participants are covered by Novartis AG, Pfizer Inc., Johnson & Johnson and Abbott Laboratories
- insightful discussion of key industry drivers, constraints and challenges. Each trend is independently researched to provide qualitative analysis of the effects
-. The main topics include strategic competitor assessment, market characterization, unmet needs and the implications for future market development associated with osteoarthritis of the market

The report will improve your ability to make decisions faster, time-critical. It allows you to:
- development and design of your licensing and licensing strategies by examining the pipeline products and technologies and by identifying companies with outstanding pipeline
- developing business strategies by understanding. Trends shaping and driving the global market osteoarthritis.
- sales training by understanding the key trends, innovative products and technologies, market segments and companies that could affect the world market in the future
osteoarthritis, -. Formulate effective strategies for sales and marketing by understanding the competitive environment and analyzing the performance of different competitors.
- Identify emerging players with potentially strong product portfolio and develop strategies to counter-a competitive advantage.
- Organize your marketing and sales activities by identifying the categories and market segments that have the maximum opportunities for consolidations, investments and strategic partnerships
1.1 List of Tables 4 1.2 List of Figures 4

5 2.1 Overview 2.2 Market Size Osteoarthritis Therapeutics 5
2.3 Forecast Market CAGR osteoarthritis and
6 2.4 Drivers and barriers to market the arthritis Therapeutics
2.4 7 0.1 Market Drivers for Osteoarthritis Therapeutics 7
2.4.2 Obstacles to the Osteoarthritis Therapeutics Market
8 2.5 opportunities and unmet needs
8 9 2.6 Main-win

3.1 Overview 10 3.2 Evaluation 10 strategic competitor
3.3 Details of the products of major products marketed Osteoarthritis Therapeutics 11 3.3.1 Voltaren Gel

11 11
Celebrex 3.3.2 3.3.3 3.3.4 Hyalgan 12
Mobic 12
3.4 Key Generation Policy win 13

4.1 Overview 14 4.2 Assessment of strategic pipelines
14 4.2.1 Technology Trends Analytic Framework 14
Therapeutics osteoarthritis 4,3 – promising drugs in clinical development 15 4.4
molecular profile of promising drugs in clinical development 16 4.4.1 SD6010
16

4.4.2 PF -4,383,119 16 4.4. TDS-943 3 16 17

SMC021 4.4.4 4.4.5 4.4.6
17 CG5503 Vicodin CR 18 Market
osteoarthritis 4, 5 – a clinical pipeline of mechanism of action of 18
4.6 osteoarthritis pipeline – Pipeline Clinical Development in stages 19
4.6.1 Osteoarthritis Therapeutics – Phase III clinical pipeline 20 4.6 0.2
Osteoarthritis Therapeutics – Phase II clinical pipeline 23
Osteoarthritis Therapeutics 4.6.3 – Phase I clinical pipeline 25
4.6.4 Osteoarthritis Therapeutics – Discovery Pipeline 26 4.6.5
Osteoarthritis Therapeutics – Pipeline abandoned 26
4.7 key win 26

6.1 Introduction 28 6.2 Overview 6.2.1 Novartis Pharma AG 28 28

osteoarthritis disease 29 6.2.2 Portfolio 6.2.3 SMC021

29 6.3 Pfizer Inc 29 6.3.1 Overview 29 6.3.2 Portfolio

Disease Osteoarthritis 30
30
SD6010 6.3.3 6.3.4 PF-4383119 30
6.3.5 TDS-943 6.4 31 Johnson and Johnson 31

6.4.1 Presentation 31
Disease Arthritis Society 32 6.4.2 Portfolio 6.4.3 CG5503
32

6.5 Abbott Laboratories 32 6.5.1 Company Profile 32 6.5 0.2
Portfolio Disease Osteoarthritis 33
6.5.3 Vicodin CR 33

7.1 Definitions 34 7.2 Acronyms

34 7.3 Research Methodology 34
7.3.1 Coverage 35 7.3 .2 Secondary Research 35

7.3. 3 Forecast 36 7.3.4 Primary Research 38 7.3.5

Expert Panel Validation 39 7.4 Contact Us 39 7.5 Disclaimer

39 7.6 Sources 39

report sand reports an online library of 10 000 reports, studies in depth market research of more than 5000 micro-markets and 25 industry-specific sites. report sand reports have announced that Market Research Report in his shop. Browse our Market Research Reports Details ReportsandReports.com